• 结论供体骨髓输注形成供受体细胞的嵌合状态,可降低同种异体移植排斥反应,延长受体生存时间。

    CONCLUSION: Donor specific bone marrow infusion enhances chimerism formation in bone marrow, alleviates the rejection of liver allotransplantation and improve survival of liver allotransplantation.

    youdao

  • 目的观察不同脾细胞亚强化骨髓细胞输注调节特异性免疫状态效应探讨其可能机制

    To investigate the effect and the mechanisms of subtypes of splenocytes improving the regulatory effect on specific immune response following donor bone marrow infusion.

    youdao

  • 目的研究供体骨髓细胞输注减轻移植急性排斥反应

    Objective To study donor bone marrow infusion relieving acute rejection of rat lung allograft.

    youdao

  • 目的观察供体白细胞输注(DL I)治疗急慢性白血病多发性骨髓疗效安全性

    Objective To observe the therapeutic efficacy and safety of donor leukocyte infusion (DLI) in acute, chronic leukemia and multiple myeloma.

    youdao

  • 结论CD 8 +细胞输注强化了骨髓细胞输注调节特异性免疫状态的效应包括免疫偏移在内的机制参与一过程

    CD8 + lymphocyte infusion improves the regulatory effect on specific immune response following donor bone marrow infusion. Several mechanisms including immune deviation involve this process.

    youdao

  • 结论:同供体移植骨髓细胞输注一种可行诱导免疫耐受的方法,且简便安全

    Conclusion: Donor bone marrow transfusion was safe and beneficial. It could induce specific immunologic tolerance in the renal allograft recipients.

    youdao

  • 结论次要血型不合输注细胞患者红系恢复较快年龄大和非血缘骨髓移植的患者红系恢复

    In conclusion, the erythrocyte recovery is more quick in patients with minor ABO incompatible and more number of mononuclear cells infused, while it is slow in patents with old age and unrelated BMT.

    youdao

  • 白血病患者和进行外周血骨髓造血干细胞移植的患者,由于自身缺乏巨细胞病毒抗体他们输注成分必须巨细胞病毒抗体阴性的。

    Patients with leukemia and those undergoing blood or marrow stem cell transplantation, who themselves have no antibodies to CMV, should receive blood components that are negative for CMV antibodies.

    youdao

  • 随机双盲对照研究早期冠状动脉内移植自体骨髓细胞输注治疗急性心肌梗塞的临床试验†regenerate - ami。

    A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial †.

    youdao

  • 脐带血富含造血细胞,既可作为造血干细胞移植新的来源,又可用于骨髓抑制患者的临床输注,有广阔的应用前景。

    The umbilical cord blood included much more hematopoietic progenitor cells. The umbilical cord blood provided new source for hematopoietic cells transplantation and t...

    youdao

  • 脐带血富含造血细胞,既可作为造血干细胞移植新的来源,又可用于骨髓抑制患者的临床输注,有广阔的应用前景。

    The umbilical cord blood included much more hematopoietic progenitor cells. The umbilical cord blood provided new source for hematopoietic cells transplantation and t...

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定